Keyphrases
AIDS/HIV
33%
Antiretroviral
100%
Antiretroviral Therapy
33%
Antiviral Drugs
100%
Clinical Research Center
33%
Clinical Significance
33%
Drug Resistance
33%
Drug Resistance mutations
33%
Drug Susceptibility
100%
Drug-resistant HIV
33%
Geographic Variability
33%
HIV Patients
33%
HIV Seroconversion
33%
In(III)
33%
Infected Patients
33%
M184V
33%
Major Metropolitan Areas
33%
Multidrug Resistance
33%
Multidrug-resistant
33%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
33%
Nucleoside Reverse Transcriptase Inhibitors
33%
Patient Samples
33%
Plasma Samples
33%
Polymorphism
33%
Population-based
33%
Primary HIV Infection
100%
Protease
66%
Protease Inhibitors
33%
Resistance mutations
33%
Resistance Test
33%
Retrospective Analysis
33%
Reverse Transcriptase
66%
Sequence Analysis
66%
Viral Isolates
33%
Medicine and Dentistry
Acute HIV Infection
100%
Antiretroviral Therapy
20%
Clinical Research
20%
Clinical Significance
20%
Drug Resistance
40%
Drug Sensitivity
100%
Human Immunodeficiency Virus
100%
Multidrug Resistance
20%
Nonnucleoside Reverse Transcriptase Inhibitor
20%
Prevalence
20%
Protein Sequencing
40%
Proteinase
40%
Proteinase Inhibitor
20%
Resistance Mutation
40%
Reverse-Transcriptase Inhibitor
20%
RNA Directed DNA Polymerase
40%
Sequence Analysis
40%
Seroconversion
20%
Immunology and Microbiology
Blood Plasma
20%
Drug Resistance
40%
Drug Sensitivity
100%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
100%
Multidrug Resistance
20%
Prevalence
20%
Reverse Transcriptase
80%
Sequence Analysis
40%
Seroconversion
20%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
14%
Clinical Research
14%
Drug Resistance
28%
Drug Sensitivity
100%
Human Immunodeficiency Virus
100%
Multidrug Resistance
14%
Nucleoside
14%
Prevalence
14%
Protease
28%
Protease Inhibitor
14%
Protein Sequencing
28%
Reverse Transcriptase
57%
Seroconversion
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute HIV Infection
100%
Clinical Research
20%
Drug Resistance
40%
HIV
100%
Multidrug Resistance
20%
Nonnucleoside Reverse Transcriptase Inhibitor
20%
Prevalence
20%
Proteinase
40%
Proteinase Inhibitor
20%
RNA Directed DNA Polymerase
40%
RNA Directed DNA Polymerase Inhibitor
20%
Neuroscience
Antiretroviral Drugs
100%
Blood Plasma
14%
Drug Resistance
28%
Human Immunodeficiency Virus
100%
Protein Sequencing
28%
Proteinase
42%
Reverse Transcriptase
28%
Reverse-Transcriptase Inhibitor
28%